Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis Journal Article


Authors: Chen, J. J.; Stessin, A.; Christos, P.; Wernicke, A. G.; Nori, D.; Parashar, B.
Article Title: Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis
Abstract: Objective The purpose of this study was to investigate and compare the cause-specific survival (CSS) of stage I (tumor [T]1 node [N]0 metastasis [M]0) versus stage II (T2N0M0) glottic cancer in a large population cohort. Study Design We analyzed data from the Surveillance, Epidemiology, and End Results 18 database from 1973 to 2009, comprising patients diagnosed with T1N0M0 or T2N0M0 squamous cell glottic cancer. Kaplan-Meier survival analysis, multivariable Cox proportional hazards regression analysis, and competing-risks survival regression were used for statistical analysis. Results There were 4,422 patients who met all inclusion criteria. The 36-month CSS was 93.9% for stage I verus 86.5% for stage II, with P<0.0001. Stage II status conferred a 2.494 hazard ratio for increased risk of cause-specific death compared to stage I. Conclusions Stage II glottic cancers have a significantly worse prognosis and may need a different approach to management than stage I tumors. Level of Evidence 4. Laryngoscope, 125:2093-2098, 2015. © 2015 The American Laryngological, Rhinological and Otological Society, Inc.
Keywords: survival; radiation; t1; glottic; seer; t2
Journal Title: Laryngoscope
Volume: 125
Issue: 9
ISSN: 0023-852X
Publisher: Wiley Blackwell  
Date Published: 2015-09-01
Start Page: 2093
End Page: 2098
Language: English
DOI: 10.1002/lary.25338
PROVIDER: scopus
PUBMED: 26109043
DOI/URL:
Notes: Export Date: 2 September 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics